Assessment of Commercial and Mandatory Discounts in the Gross-to-Net Bubble for the Top Insulin Products From 2012 to 2019.
- DOI
- 10.1001/jamanetworkopen.2023.18145
- Published
- 2023 Jun 1
- Container
- JAMA network open
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1001/jamanetworkopen.2023.18145,
title = {Assessment of Commercial and Mandatory Discounts in the Gross-to-Net Bubble for the Top Insulin Products From 2012 to 2019.},
author = {Dickson SR and Gabriel N and Gellad WF and Hernandez I},
year = {2023},
journal = {JAMA network open},
doi = {10.1001/jamanetworkopen.2023.18145},
url = {https://doi.org/10.1001/jamanetworkopen.2023.18145}
}RIS
TY - JOUR TI - Assessment of Commercial and Mandatory Discounts in the Gross-to-Net Bubble for the Top Insulin Products From 2012 to 2019. AU - Dickson SR AU - Gabriel N AU - Gellad WF AU - Hernandez I PY - 2023 JO - JAMA network open DO - 10.1001/jamanetworkopen.2023.18145 UR - https://doi.org/10.1001/jamanetworkopen.2023.18145 ER -
APA
SR, D., N, G., WF, G., & I, H. (2023). Assessment of Commercial and Mandatory Discounts in the Gross-to-Net Bubble for the Top Insulin Products From 2012 to 2019.. JAMA network open. https://doi.org/10.1001/jamanetworkopen.2023.18145
Source records
- pubmed · retrieved 2026-09-25T19:47:45.337Z